Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0MQAEC
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
isumab01-C6
|
|||||
| Synonyms |
Isumab01-C6
Click to Show/Hide
|
|||||
| Organization |
MURGITROYD & COMPANY
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
3.3
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Folate receptor alpha (FOLR1)
|
Antigen Info | ||||
| Payload Name |
WO2025015586A1, ADC24, Payload
|
Payload Info | ||||
| Therapeutic Target |
Toll-like receptor 7 (TLR7); Toll-like receptor 8 (TLR8)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
General Information of The Activity Data Related to This ADC
Revealed Based on the Cell Line Data
Full List of Activity Data of This Antibody-drug Conjugate
Revealed Based on the Cell Line Data
| Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) | 0.002 pM | High FRa expression (FRa +++) | ||
| Method Description |
A Cell line test on Colo205
|
||||
| In Vitro Model | Colon adenocarcinoma | Colo205 cells | CVCL_0218 | ||
| Experiment 2 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) | 8 pM | High FRa expression (FRa +++) | ||
| Method Description |
A Cell line test on H2110
|
||||
| In Vitro Model | Lung non-small cell carcinoma | H2110 cells | CVCL_1530 | ||
| Experiment 3 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) | 9 pM | High FRa expression (FRa +++) | ||
| Method Description |
A Cell line test on Jeg3
|
||||
| In Vitro Model | Gestational choriocarcinoma | Jeg3 cells | CVCL_0363 | ||
